Seres Therapeutics Inc. (MCRB)

AI Score

Unlock

0.68

0.00 (0.29%)

At close: Apr 03, 2025, 3:59 PM

0.67

-1.89%

Pre-market: Apr 04, 2025, 08:37 AM EDT

Seres Therapeutics Balance Sheet Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Cash & Equivalents	30.79M	127.97M	163.03M	180M	116.05M	65.13M	85.82M	36.09M	54.54M	73.93M	114.19M	1.65M	6.21M
Short-Term Investments	n/a	n/a	18.31M	110.7M	137.57M	29.69M	n/a	113.89M	138.7M	131.15M	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	9.59M	495K	49.83M	1.4M	1.4M	1.51M	36.75M	1.54M	n/a	n/a	n/a
Other Long-Term Assets	8.7M	50.94M	10.46M	14.59M	1.4M	n/a	113K	n/a	1.4M	n/a	1.84M	68K	-266K
Receivables	4.75M	8.67M	n/a	n/a	9.39M	1.78M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	29.65M	n/a	n/a	1.00	-29.69M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	3.13M	9.12M	13.42M	12.92M	5.77M	n/a	6.84M	n/a	n/a	n/a	n/a	n/a	30K
Total Current Assets	38.67M	175.41M	194.76M	303.63M	268.78M	100.19M	92.67M	155.08M	198.37M	207.61M	114.24M	1.71M	6.25M
Property-Plant & Equipment	92.44M	132.25M	133.97M	36.15M	22.94M	30.85M	26.29M	32.93M	36.13M	7.75M	1.26M	352K	266K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	101.14M	183.19M	154.02M	51.23M	74.16M	32.25M	27.81M	34.44M	74.28M	9.29M	3.1M	420K	266K
Total Assets	139.81M	358.6M	348.78M	354.86M	342.94M	132.44M	120.47M	189.52M	272.65M	216.9M	117.34M	2.13M	6.54M
Account Payables	4.08M	3.64M	17.44M	13.73M	4.02M	4.86M	6.42M	7.03M	7.59M	5.4M	2.17M	393K	112K
Deferred Revenue	n/a	7.73M	4.26M	16.82M	22.6M	25.79M	20.42M	12.08M	12.06M	n/a	1.46M	248K	n/a
Short-Term Debt	8.67M	n/a	456K	6.61M	454K	4.46M	n/a	n/a	n/a	n/a	1.2M	400K	n/a
Other Current Liabilities	28.47M	64.15M	90.26M	29.27M	14.98M	3.64M	n/a	n/a	n/a	n/a	n/a	n/a	66K
Total Current Liabilities	41.22M	98.66M	85.6M	82.26M	46.41M	45.99M	42.04M	31.63M	30.46M	10.92M	5.1M	1.06M	178K
Long-Term Debt	82.97M	101.54M	50.59M	24.64M	24.64M	24.65M	n/a	n/a	n/a	n/a	1.3M	438K	n/a
Other Long-Term Liabilities	1.84M	2.17M	1.44M	11.49M	1M	502K	9.64M	12.35M	12.8M	586K	137.66M	11.75M	n/a
Total Long-Term Liabilities	84.8M	304.8M	252.41M	141.09M	121.78M	134.77M	126.48M	97.2M	109.56M	586K	138.96M	12.19M	n/a
Total Liabilities	126.03M	403.46M	338M	223.35M	168.19M	180.76M	168.52M	128.82M	140.01M	11.51M	144.07M	13.24M	178K
Total Debt	91.64M	213.94M	162.59M	49.21M	40.77M	44.78M	7.25M	8.99M	10.73M	n/a	2.5M	838K	n/a
Common Stock	173K	135K	125K	92K	91K	70K	41K	40K	40K	39K	7K	7K	7K
Retained Earnings	-978.1M	-978.24M	-864.51M	-614.35M	-548.78M	-459.65M	-389.37M	-263.57M	-174.19M	-82.61M	-27.83M	-11.12M	-4.36M
Comprehensive Income	n/a	n/a	-12K	-60K	-47K	n/a	-20.3M	-146K	-149K	30K	-137.66M	n/a	n/a
Shareholders Equity	13.78M	-44.86M	10.78M	131.51M	174.75M	-48.32M	-48.05M	60.7M	132.63M	205.39M	-26.72M	-11.12M	6.36M
Total Investments	n/a	9.59M	18.31M	111.2M	187.39M	31.09M	1.4M	113.89M	175.46M	131.15M	n/a	n/a	n/a